DÄ internationalArchive48/2018Medicine in the Penal System

Review article

Medicine in the Penal System

Dtsch Arztebl Int 2018; 115: 808-14. DOI: 10.3238/arztebl.2018.0808

Opitz-Welke, A; Lehmann, M; Seidel, P; Konrad, N

Background: Infectious diseases, substance dependencies, and dental diseases are the most important health problems affecting incarcerated persons. In Germany, for example, prisoners are 48 to 69 times more likely to be infected with the hepatitis C virus (HCV) than the general population, and 7 to 12 times more likely to be infected with the human immunodeficiency virus (HIV). The prevalence of mental illnesses is also markedly higher in the incarcerated than in the general population.

Methods: This review is based on pertinent publications retrieved by a selective search in two databases (PubMed and Google Scholar) for any of the terms “health care,” “primary health care,” “mental health care”; “infectious disease,” “opioid maintenance treatment,” and “severe mental disorder” in conjunction with “prison,” “jail,” “detention,” and “incarceration.”

Results: Among prisoners in German prisons, approximately 20% consume heroin, 20–50% suffer from alcohol dependency and abuse, and 70–85% smoke. The prevalence of tuberculosis in German prisons in 2002 was 0.1%. The provision of needles to incarcerated persons has a preventive effect on infection with hepatitis C, hepatitis B, and HIV, yet programs of this type have been discontinued in most penal facilities. In a systematic review, psychotic disorders were found in 3.6% (95% confidence interval [CI]: [3.1; 4.2]) of male inmates and 3.9% [95% CI: 2.7; 5.0] of female inmates. 25% of incarcerated persons suffer from attention-deficit—hyperactivity disorder. Persons recently released from prison have an above average mortality, largely due to drug intoxication.

Conclusion: An analysis of medical prescribing data reveals deficiencies in the provision of HCV treatment to all affected persons and in the provision of substitution treatment to persons with opiate dependency. In view of the known risks associated with imprisonment, greater emphasis should be placed on the provision of treatment for infectious diseases, substance dependencies, and mental illness, both in prison and in outpatient care after release.

LNSLNS

In international comparison, Germany is among those countries that have a low rate of prisoners relative to the size of its population (e1). The medical care of prisoners does not fall under the remit of the statutory health insurance schemes. Medical services are funded directly by the law enforcement authorities, with the extent of medical services regulated according to the so called equivalence principle, which stipulates that prison medical services should be equivalent to those provided by statutory health insurers (1). Table 1 shows the epidemiological characteristics of prisoners compared with the German population (e2e5).

Comparison of medical care for the resident population and prisoners
Comparison of medical care for the resident population and prisoners
Table 1
Comparison of medical care for the resident population and prisoners

The medical parameters in the existing penal healthcare system are not collected centrally; for this reason a direct comparison between intramural and extramural medical services is not possible.

In terms of providing healthcare services within the penal system, prison doctors have a key role; their clinics are open to all prisoners. On admission into the penal system, prison doctors undertake a basic medical examination of every prisoner, during which they systematically inquire about the prisoner’s general health and document their physical findings (2, 3).

In a study from Belgium, the most common reasons for contact with a doctor were administrative and psychiatric questions (35.1%). The so-called administrative questions reflect the institutional regulation—typical of the penal system—of the entire way of life. Individual wishes, such as the need and desire for different dietary provisions or a second pillow, also led to a consultation with the responsible prison doctor. Respiratory symptoms (12.9%) or gastrointestinal problems (12.5%) were the second most common causes for consulting a doctor in the Belgian study, followed by musculoskeletal symptoms and skin disorders (7.7%) (3).

No studies are available of the frequency distributions of different reasons for medical consultations in Germany’s penal facilities; in our experience the distribution mentioned in the Belgian study roughly corresponds with conditions in German prisons. Inpatient medical services are delivered in sick wards and prison hospitals, some of which also have psychiatric departments. Only in exceptional circumstances will prison inmates be transferred to external hospitals for treatment, under close guard.

Physical/somatic health problems in prison: prevalence and primary prevention

In 2007, the World Health Organization (WHO) identified communicable diseases, dependency/addiction disorders, and dental disorders as the most important primary care problems in prisons (e6).

Table 2 summarizes the results of a literature search of the frequency of somatic/physical health impairments in prisoners (7, e7e12).

Rates of health impairments and causes of death in prison inmates
Rates of health impairments and causes of death in prison inmates
Table 2
Rates of health impairments and causes of death in prison inmates

International studies of the prevalence of nicotine dependence in the penal system found a rate of 70–83% of smokers; according to a short report from the German Institute on Addiction and Prevention Research, 85% of those imprisoned in German jails were smokers (4).

An analysis of pooled data from 2005 to 2015 showed an association between repeated stays in prison of HIV positive drug addicts and the HIV prevalence in the corresponding general population (5). Screening and treatment services for prisoners infected with hepatitis C and hepatitis B virus (HBC and HBV) and HIV, as well as other sexually transmitted infections, were identified as effective measures for reducing the infection rate in the relevant general population (6). A 2006 cross-sectional study conducted by the Robert Koch-Institute found in German prisoners with a history of injecting drug use (29% of the total sample) a proportion of inmates with HCV antibodies of 57.6% (95% confidence interval [56.6; 58.7]) and with HIV antibodies of 1.3% [95% CI: 1.1; 1.5] (7). Table 3 shows the prevalence of viral hepatitis, HIV infections, and tuberculosis (TB) in German prisoners compared with the general population (6, 7, e8, e13e16).

Communicable diseases in the general population versus prison population in Germany
Communicable diseases in the general population versus prison population in Germany
Table 3
Communicable diseases in the general population versus prison population in Germany

With regard to TB, Germany is a low-incidence country (8). As prisoners often come from at-risk populations with a raised prevalence and incidence of TB, TB is more common in prisoners than in the general population (9). The diagnosis of a TB infection at the very start of a spell in prison enables effective treatment as well as protection from infection. To this end, active case finding is required after admission into the penal system (e17, e18). The German Protection against Infection Act (e19) stipulates a duty to undergo the necessary screening, which includes the option of an x-ray.

Nationwide data on the prevalence of TB in penal institutions are not available. In Berlin’s penal system in 2002, a TB prevalence of 0.1% was found (e20). Infection with HIV increases the risk of TB. Prisoners infected with HIV have a relative risk of 2.0–10.75 of contracting TB (10).

The prevalence of psychiatric disorders in the penal system

The prevalence of psychiatric disorders in prisoners is increased compared with the general population. A systematic review and meta-analysis of studies covering the time period 1966–2010 found in 33 588 prisoners a raised prevalence of psychosis and severe depression compared with the general population (11). Psychotic disorders were seen in 3.6% [95% CI: 3.1; 4.2] of male prisoners and 3.9% [95% CI: 2.7; 5.0] of female prisoners, and severe depression in 10.2% [95% CI: 8.8; 11.7] of male prisoners and 14.1% [95% CI: 10.2; 18.1] of female prisoners. The study in question did not differentiate by etiology of psychotic disorder; based on the authors’ clinical experience we may assume that most cases were patients with schizophrenia and psychotic disorders subsequent to drug misuse.

Very few studies have investigated the prevalence of psychiatric disorders in German prisoners. Their results are summarized in Table 4 (e21e26). Representative samples have thus far been analyzed only in prisoners who are jailed rather than paying a fine and remand prisoners. Although neither of the currently used international classification systems ICD-10 (WHO) and DSM-5 (APA) include this diagnostic category, and although no clinical studies have confirmed a separate entity, the diagnosis of prison psychosis has persisted for decades. The term describes a schizophreniform disorder or schizophrenia that develops as a reaction to the imprisonment itself and is said to have distinct symptoms from psychosis that occurs outside the prison environment (12).

Psychiatric disorders in prisoners
Psychiatric disorders in prisoners
Table 4
Psychiatric disorders in prisoners

The prevalence of attention deficit hyperactivity disorder (ADHD) in prisoners is notably higher than in the general population, and according to the results of a recent meta-analysis, 25.5% of all prisoners are affected (13, e27, e28). In a Swedish registry study, in a group of 25 565 documented persons with a diagnosis of ADHD, those who had received treatment were less likely to be offenders. Comparing phases with and without treatment between patients showed that criminality rates were significantly reduced by 32% in men (estimated hazard ratio 0.68 [95% CI: 0.63; 0.73]) and 41% in women during periods on ADHD medication (estimated HR 0.59 [95% CI: 0.50; 0.70]) (14).

The fact that the suicide rate in prisoners compared with that in the general population is notably higher can be considered to be an expression of the psychosocial stress and increased mental vulnerability of prisoners (1517). Table 5 shows suicides in Germany. In 2000–2011, the suicide rate in male prisoners in German prisons was 5.6 times higher, and in female prisoners 8.5% higher than in the general population (18). There is a consensus that suicide screening at admission into the penal system is an important measure for preventing prison suicide. Two German-language screening instruments are available for this purpose (19, e29, e30). Screening instruments systematically interrogate the known risk factors for suicide in prison; if the screening yields positive findings the prisoner will immediately be referred to specialist medical or psychological services.

Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)
Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)
Table 5
Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)

Evidence based medical care for prisoners

Screening for communicable diseases and their treatment and prevention

The medical care of prisoners should correspond to general practice outside the penal system. This includes the provision of all screening examinations covered by the statutory health insurers. Prisoners’ vaccination status at admission should be examined and their immunization should be updated according to the valid recommendations of the Standing Vaccination Committee (STIKO). Furthermore, at admission and during the further course of the imprisonment, all prisoners should be offered screening tests for HCV, HBV, HIV, and condoms should be made available free of charge (20). Prisoners who have a communicable disease should receive extensive care from a multiprofessional team in the setting of an intramural consultation and should be referred to specialized medical practices for infectious diseases after discharge (21).

A European comparison of infection prevention measures in the penal system in 2015 found substantial deficiencies in the implementation of valid WHO recommendations in all countries under study (none of the prisons under study provided needle exchange programs, and only some provided postexposure prophylaxis, disinfectants for sterilizing injection needles/syringes, and HBV vaccination); no German prisons were included in this study (22).

Studies of the practice of needle/syringe provision in the penal system have found a preventive effect for infection with hepatitis C and hepatitis B virus, as well as HIV. In a study in prisoners in Berlin, the practice of swapping needles fell from 71% to 11% after a needle/syringe program had been introduced (23). The fact that some prisons tolerated the use of illegal drugs that were injected with the needles/syringes that had been made available prompted political controversy and resulted in withdrawal of needle/syringe programs in most prisons (24).

Recent systematic studies of other measures for reducing the transmission risk for communicable diseases in Germany are not available, but an analysis of prescribing data of antiretroviral, tuberculostatic, and anti-HCV medication in German prisons imply that those infected with TB and HIV are being treated according to the estimated prevalence, whereas gaps prevail in the comprehensive availability of HCV treatment and substitution treatment in opiate addiction (25).

Self-harming behavior, ingestion of foreign bodies, and hunger strikes

Self harming behavior is common in prisoners but less well studied as a phenomenon than suicidality. An epidemiological study of 26 510 Welsh prison inmates found self harming behavior in 5–6% of imprisoned men and 20–24% of imprisoned women (26). Injuries caused by cutting or scratching were the most common method used for self-harming, and suicide rates in this group was very high (men 450/100 000 [95% CI: 360–550/100 000], women 260/100 000 [95% CI: 140–430/100 000]). The presence of a mental disorder, especially depression, was associated with an increased probability of self-harming behavior (odds ratio in men 42.0, in women 23.7) (27). In studies of the causes of self-harming behavior in prisoners, the most commonly reported individual motivation for self-harm was a desire to regulate tension and interpersonal conflicts (28). In our experience, self-harm can also be observed in persons who experience their prison conditions as particularly stressful and express the desire to improve their situation by being transferred to another prison area.

Swallowing foreign bodies constitutes a particular form of self-harming behavior, which is well known in penal institutions worldwide. In Germany, rates of self-harming behavior have so far not been centrally documented; international studies reported a rate of 1:1900 prisoners for swallowing foreign bodies. Mostly, smaller foreign bodies are ingested, such as razor blades or paper clips (29). In most cases, narrow foreign bodies up to a length of 10 cm are evacuated naturally within a few days, without the need for invasive measures (30).

Hunger strikes as a form of protest have a long tradition in the penal system. Systematic studies have shown that 70–80% of hunger strikers in prisons end their abstinence from food after less than seven days (e31). A hunger period of 40 days is mostly tolerated without lasting damage in healthy hunger strikers; depending on the individual nutritional status at the start of the strike, continuous abstinence from food can lead to a life-threatening state after 6–10 weeks (e32). Prisoners who embark on a hunger strike should be presented to a specialist psychiatrist so as to rule out any—albeit rare—delusional motivation for refusing food intake. In case of a lengthy hunger strike, the threat arises of a conflict between the legal options, of force feeding according to valid penal law enforcement and the fact that force feeding is prohibited according to medical ethics and the professional code—for example, that of the World Medical Association (WMA) (e33). No centralized data collection of hunger strikers exists in the German penal system. As far as we are aware, no fatal outcomes of hunger strikes have been reported in Berlin and Brandenburg in the past 10 years.

Addiction medicine

In 2016, 6415 persons—12.6% of all prison inmates—were incarcerated in penal institutions because of offenses against the German Narcotic Drugs Act (Betäubungsmittelgesetz, BtMG). The number of prisoners with opiate addiction, however, should be considered to be notably greater (e34). In the representative cross-sectional study of German prison inmates conducted by the Robert Koch-Institute in 2006–7, a third (29.7%) reported ever having injected drugs, 37.7% answered in the affirmative to the question of whether they had ever consumed heroin, 22.7% reported consuming drugs inside and outside penal institutions, 12.5% reported consuming drugs only outside and 2.5% only inside (7). Systematic studies of which drugs make their way into Germany’s prisons, and how they do so, do not exist.

In our experience, all illegal drugs are offered in Germany’s penal institutions on the internal black market. Payment is either completed by persons outside the prison or within the internal black market by means of payment in kind, prostitution, cigarettes, or coffee. It can be assumed that the substances are mostly imported by visitors, occasionally prison staff. Alcohol in the form of fermented carbohydrate-containing foods is mostly produced by the inmates themselves. According to our own clinical experience, the alcohol content of these products can be up to 10 volume percent. Occasionally, inmates consume medicinal alcohol in the shape of disinfectant sprays or hand disinfectants that contain highly concentrated ethyl alcohol but also propyl alcohol, which is far more intoxicating (e35).

Guideline-conform treatment of addiction-specific disorders in the penal system is hampered by the lacking free access to outpatient addiction services. Because medical parameters in the prison health system are not centrally collected, no data are available in this area either. According to the German Monitoring Centre for Drugs and Drug Addiction (Deutsche Beobachtungsstelle für Drogen und Drogensucht, DBDD), in 2016, 80% of opiate-dependent women were treated during their prison sentence, but only a quarter of the imprisoned men with opiate dependency (e36).

Because proportions of prisoners with dependency/addiction disorders are high, opiate and alcohol withdrawal symptoms are often observed at the start of the prison sentence. Qualified withdrawal treatment should be provided as a matter of principle (31). In systematic reviews, substitution treatment with methadone or buprenorphine has been found to be superior to abstinence-oriented treatment in opiate dependency addiction (e37). For this reason, and also because of the described protective effect against infections, ongoing opiate substitution treatment at the start of a prison sentence should be continued without complications, and where the indication exists, opiate substitution treatment during the prison sentence should be easily accessible at all times (32).

Preparation for discharge and interface management

Retrospective cohort studies have found above average mortality in discharged prisoners (33). In the decade 1999 to 2009, Binswanger et al. found in a cohort of 70 208 discharged prisoners that the risk of dying was 3.6% [95% CI: 3.48%; 3.73%] higher than in the general population. Drug intoxication, using opioids in 77% of cases, was the leading cause of death in discharged prisoners (34, 35). Most deaths from overdose occurred within the first four weeks after discharge from prison (relative risk 1.7 [95% CI: 1.3; 2.2]) (36). In a retrospective analysis of the cause of death statistic in 16 453 Australian prison inmates, continuing opioid substitution treatment was associated with the lowest risk of death from drug intoxication (37). In awareness of these risks, services providing treatment for infectious diseases and psychiatric-addiction disorders in German penal institutions should prepare the transition into an outpatient treatment setting (38, 39). In an international systematic review, the development of 12 056 offenders with psychiatric disorders was studied. The rate of criminal relapse of 4484/100 000 was lower than that of a comparable group of prison inmates without psychiatric follow-up care (40).

Conflict of interest statement
The authors declare that no conflict of interest exists.

Manuscript received on 12 February 2018, revised version accepted on
12 July 2018.

Translated from the original German by Birte Twisselmann, PhD.

Corresponding author
Dr. med. Annette Opitz-Welke

Justizvollzugskrankenhaus Berlin in der JVA Plötzensee

Friedrich-Olbricht-Damm 16,
13627 Berlin

annette.opitz-welke@charite.de

Supplementary material

For eReferences please refer to:
www.aerzteblatt-international.de/ref4818

1.
Meier BD: Ärztliche Versorgung im Strafvollzug: Äquivalenzprinzip und Ressourcenknappheit. In: Hillenkamp T, Tag B (eds.): Intramurale Medizin – Gesundheitsfürsorge zwischen Heilauftrag und Strafvollzug. Berlin, Heidelberg: Springer 2005: 35–55 CrossRef
2.
Keppler K, Stover H, Schulte B, Reimer J: [Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany. A review]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53: 233–44 CrossRef MEDLINE
3.
Feron JM, Paulus D, Tonglet R, Lorant V, Pestiaux D: Substantial use of primary health care by prisoners: epidemiological description and possible explanations. J Epidemiol Community Health 2005; 59: 651–5 CrossRef MEDLINE PubMed Central
4.
Parker DR, Fallone D, Martin RA, et al.: The relation between smoking status and medical conditions among incarcerated adults. J Addict Med 2014; 8: 90–5 CrossRef MEDLINE PubMed Central
5.
Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP: Dynamic models of infectious disease transmission in prisons and the general population. Epidemiol Rev 2018; 40: 40–57 CrossRef MEDLINE
6.
Dolan K, Wirtz AL, Moazen B, et al.: Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 2016; 388: 1089–102 CrossRef
7.
Zimmermann R, Radun D: DrogengebraucherInnen, Infektionen und Haft. Schriftenreihe Gesund­heits­förder­ung im Justizvollzug 2014; Band 28: 13–31.
8.
Ziegler R, Just HM, Castell S, et al.: [Tuberculosis infection control—recommendations of the DZK]. Gesundheitswesen 2012; 74: 337–50 CrossRef MEDLINE
9.
Aerts A, Hauer B, Wanlin M, Veen J: Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 2006; 10: 1215–23 MEDLINE
10.
Edge CL, King EJ, Dolan K, McKee M: Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc 2016; 19: 20960 CrossRef MEDLINE PubMed Central
11.
Fazel S, Seewald K: Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry 2012; 200: 364–73 CrossRef MEDLINE
12.
Gößling J, Konrad N: Zur Entität der sogenannten Haftpsychose. Recht und Psychiatrie 2004; 22: 123–9.
13.
Young SJ, Adamou M, Bolea B, et al.: The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK adult ADHD network and criminal justice agencies. BMC Psychiatry 2011; 11: 32 CrossRef MEDLINE PubMed Central
14.
Ginsberg Y, Lindefors N: Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. Br J Psychiatry 2012; 200: 68–73 CrossRef MEDLINE
15.
Fazel S, Cartwright J, Norman-Nott A, Hawton K: Suicide in prisoners: a systematic review of risk factors. J Clin Psychiatry 2008; 69: 1721–31 CrossRef MEDLINE
16.
Felthous AR: Suicide behind bars: trends, inconsistencies, and practical implications. J Forensic Sci 2011; 56: 1541–55 CrossRef MEDLINE
17.
Konrad N, Welke J, Opitz-Welke A: Prison psychiatry. Curr Opin Psychiatry 2012; 25: 375–80 CrossRef
18.
Opitz-Welke A, Bennefeld-Kersten K, Konrad N, Welke J: Prison suicides in Germany from 2000 to 2011. Int J Law Psychiatry 2013; 36: 386–9 CrossRef MEDLINE
19.
Gould C, McGeorge T, Slade K: Suicide screening tools for use in incarcerated offenders: a systematic review. Arch Suicide Res 2018; 22: 345–64 CrossRef MEDLINE
20.
Bielen R, Stumo SR, Halford R, et al.: Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J 2018; 15: 25 CrossRef MEDLINE PubMed Central
21.
Wirtz AL, Yeh PT, Flath NL, Beyrer C, Dolan K: HIV and viral hepatitis among imprisoned key populations. Epidemiol Rev 2018; 40: 12–26 CrossRef MEDLINE
22.
Michel L, Lions C, van Malderen S, et al.: Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern. BMC Public Health 2015; 15: 1093 CrossRef MEDLINE PubMed Central
23.
Stark K, Herrmann U, Ehrhardt S, Bienzle U: A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect 2006; 134: 814–9 CrossRef MEDLINE PubMed Central
24.
Karakaya S: Auswirkungen der Spritzenvergabe im Justizvollzug auf Drogenkonsumverhalten mit Hepatitis B, C und HIV. Universitätsmedizin Berlin. Berlin: Charite 2009: 106.
25.
Muller J, Schmidt D, Kollan C, Lehmann M, Bremer V, Zimmermann R: High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany. BMC Public Health 2017; 17: 843 CrossRef MEDLINE PubMed Central
26.
Hawton K, Linsell L, Adeniji T, Sariaslan A, Fazel S: Self-harm in prisons in England and Wales: an epidemiological study of prevalence, risk factors, clustering, and subsequent suicide. Lancet 2014; 383: 1147–54 CrossRef
27.
Marzano L, Hawton K, Rivlin A, Smith EN, Piper M, Fazel S: Prevention of suicidal behavior in prisons. Crisis 2016; 37: 323–34 CrossRef MEDLINE PubMed Central
28.
Gardner KJ, Dodsworth J, Klonsky ED: Reasons for non-suicidal self-harm in adult male offenders with and without borderline personality traits. Arch Suicide Res 2016; 20: 614–34 CrossRef MEDLINE
29.
Evans DC, Wojda TR, Jones CD, Otey AJ, Stawicki SP: Intentional ingestions of foreign objects among prisoners: a review. World J Gastrointest Endosc 2015; 7: 162–8 CrossRef MEDLINE PubMed Central
30.
Blaho KE, Merigian KS, Winbery SL, Park LJ, Cockrell M: Foreign body ingestions in the emergency department: case reports and review of treatment. J Emerg Med 1998; 16: 21–6 CrossRef
31.
Mir J, Kastner S, Priebe S, Konrad N, Strohle A, Mundt AP: Treating substance abuse is not enough: comorbidities in consecutively admitted female prisoners. Addict Behav 2015; 46: 25–30 CrossRef MEDLINE
32.
Fazel S, Hayes AJ, Bartellas K, Clerici M, Trestman R: Mental health of prisoners: prevalence, adverse outcomes, and interventions. Lancet Psychiatry 2016; 3: 871–81 CrossRef
33.
Kouyoumdjian FG, Andreev EM, Borschmann R, Kinner SA, McConnon A: Do people who experience incarceration age more quickly? Exploratory analyses using retrospective cohort data on mortality from Ontario, Canada. PLoS One 2017; 12: e0175837 CrossRef CrossRef MEDLINE PubMed Central
34.
Binswanger IA, Blatchford PJ, Mueller SR, Stern MF: Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 2013; 159: 592–600 CrossRef MEDLINE PubMed Central
35.
Groot E, Kouyoumdjian FG, Kiefer L, et al.: Drug toxicity deaths after release from incarceration in Ontario, 2006–2013: review of coroner‘s cases. PLoS One 2016; 11: e0157512 CrossRef MEDLINE PubMed Central
36.
Merrall EL, Kariminia A, Binswanger IA, et al.: Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105: 1545–54 CrossRef MEDLINE PubMed Central
37.
Degenhardt L, Larney S, Kimber J, et al.: The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction 2014; 109: 1306–17 CrossRef MEDLINE
38.
Mundt AP, Kastner S, Mir J, Priebe S: Did female prisoners with mental disorders receive psychiatric treatment before imprisonment? BMC Psychiatry 2015; 15: 5 CrossRef MEDLINE PubMed Central
39.
Larney S, Kopinski H, Beckwith CG, et al.: Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 2013; 58: 1215–24 CrossRef MEDLINE PubMed Central
40.
Fazel S, Fiminska S, Cocks C, Coid J: Patient outcomes following discharge from secure psychiatric hospitals: systematic review and meta-analysis. Br J Psychiatry 2016; 208: 17–25 CrossRef MEDLINE PubMed Central
e1.
Wamsly R: World prison population list. London: International Center for Prison Studies. 2016; 11.
e2.
Statistisches Bundesamt: Bestand der Gefangenen und Verwahrten in den deutschen Justizvollzugsanstalten. Rechtspflege 2017: 1–55.
e3.
DKG: Eckdaten Krankenhausstatistik. www.dkgev.de/media/file/64821.Eckdaten_Krankenhausstatistik_Stand_2017–10–05.pdf (last accessed on 29 July 2018).
e4.
Keppler K: Versorgung in Krankenhäusern des Justizvollzugs. In: Keppler K, Stöver H (eds): Gefängnismedizin Stuttgart, Thieme 2009.
e5.
KBV: Gesundheitsdaten. http://gesundheitsdaten.kbv.de/cms/html/16393.php (last accessed on 29 July 2018)
e6.
Møller L, Stöver H, Jürgens R, Gatherer A, Nikogosian H: Health in prisons. WHO 2007. http://www.euro.who.int/__data/assets/pdf_file/0009/99018/E90174.pdf (last accessed on 29 July 2018).
e7.
Baillargeon J, Black SA, Pulvino J, Dunn K: The disease profile of Texas prison inmates. Ann Epidemiol 2000; 10: 74–80 CrossRef
e8.
Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J: Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Int J Prison Health 2009; 5: 33–44.
e9.
Maruschak LB, Berzofsky M, Unangst J: Medical problems of state and federal prisons and jail inmates. U.S. Department of Justice 2015. www.bjs.gov/content/pub/pdf/mpsfpji1112.pdf (last accessed 29 July 2018).
e10.
Moschetti K, Stadelmann P, Wangmo T, et al.: Disease profiles of detainees in the Canton of Vaud in Switzerland: gender and age differences in substance abuse, mental health and chronic health conditions. BMC Public Health 2015; 15: 872 CrossRef MEDLINE PubMed Central
e11.
Binswanger IA, Krueger PM, Steiner JF: Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health 2009; 63: 912–9 CrossRef MEDLINE
e12.
Kouyoumdjian FG, Kiefer L, Wobeser W, Gonzalez A, Hwang S: Mortality over 12 years of follow up in people admitted to provincial custody in Ontarion: a retrospective cohort study. CAMJ Open 2016; 4: E153–61 CrossRef MEDLINE PubMed Central
e13.
RKI: Epidemiologisches Bulletin 2018; 11/12. Tuberkulose bleibt eine Herausforderung – auch für Deutschland. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben 11–12_18.pdf?__ blob=publicationFile (last accessed on 29 July 2018).
e14.
Kamarulzaman A, Reid SE, Schwitters A, et al.: Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet 2016; 388: 1115–26 CrossRef
e15.
RKI: Schätzung der Zahl der HIV-Neuinfektionen und der Gesamt-zahl von Menschen mit HIV in DeutschlandEpidemiologisches Bulletin 2017; 47. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/47_17.pdf?__blob=publicationFile (last accessed on 28. August 2018).
e16.
RKI: Hepatitis C im Jahr 2016. Epidemiologisches Bulletin 2017; 30. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/30_17.pdf?__blob=publicationFile (last accessed on 29 July 2018).
e17.
Paquette K, Cheng MP, Kadatz MJ, Cook VJ, Chen W, Johnston CJ: Chest radiography or active tuberculosis finding in the homeless: a systematic review and meta-analysis. Inter J Tuberc Lung Dis 2014; 18: 1231–6 CrossRef MEDLINE
e18.
Farhoudi B, Seyed Alinaghi S, Hosseini M, et al.: Prevalence of tuberculosis in a prison in Tehran by active case finding. Infect disord drug targets 2018. [Epub ahead of print]
e19.
Bundesministeriums der Justiz und für Verbraucherschutz in Zusammenarbeit mit der juris GmbH: Justiz Bd: IfSG 2001. www.gesetze-im-internet.de/ifsg/IfSG.pdf (last accessed on 29 July .2018).
e20.
Bös L: Tuberkulose im Justizvollzug. Ergebnisse einer Arbeitstagung. DZK 2013. www.rki.de/DE/Content/InfAZ/T/Tuberkulose/WTBTag2014/Vortrag_06.pdf?__blob=publicationFile (last accessed on 29 July 2018).
e21.
Konrad N: Ersatzfreiheitsstrafe Psychische Störungen, forensische und soziodemographische Aspekte. ZfstrVo 2003: 216–23.
e22.
Missoni L, Utting FM, Konrad N: Psychi(atri)sche Störungen bei Untersuchungsgefangenen. Ergebnisse und Probleme einer epidemiologischen Studie. ZfStrVo 2003: 323–32.
e23.
von Schonfeld CE, Schneider F, Schroder T, Widmann B, Botthof U, Driessen M: [Prevalence of psychiatric disorders, psychopathology, and the need for treatment in female and male prisoners]. Nervenarzt 2006; 77: 830–41 MEDLINE
e24.
Müller-Foti G, Roberts FJ, Schildbach S, Wickenhäuser R: Punishing the disorientaded. Int J Prisoner Health 2007: 115–23.
e25.
Dudeck M, Kopp D, Kuwert P, et al.: [Prevalence of psychiatric disorders in prisoners with a short imprisonment: results from a prison in north Germany]. Psychiatr Prax 2009; 36: 219–24 CrossRef MEDLINE
e26.
Schildbach S: Ersatzfreiheitsstrafe. Unterensingen: Saturia 2015; 245–86.
e27.
Young S, Moss D, Sedgwick O, Fridman M, Hodgkins P: A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psycholg Med.2015 Jan; 45 (2): 247–78 CrossRef MEDLINE PubMed Central
e28.
Rosler M, Retz W, Yaqoobi K, Burg E, Retz-Junginger P: Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 2009; 259: 98–105 CrossRef MEDLINE
e29.
Frottier P, Koenig F, Seyringer M, Matschnig T, Fruehwald S: The distillation of „VISCI“: towards a better identification of suicidal inmates. Suicide Life Threat Behav 2009; 39: 376–85 CrossRef MEDLINE
e30.
Lohner J, Konrad N: Deliberate self harm and suicide attempt in custody: distinguishing featurs in male inmates‘ self injourious behaviour. Int J Law Psychiatry 2006; 29: 370–85 CrossRef MEDLINE
e31.
Reeves R, Tamburello AC, Platt J, Tepper D, Edelman K: Characteristics of inmates who initiate hunger strikes. J Am Acad Psychiatry Law 2017; 45: 302–10 MEDLINE
e32.
Johnstone AM: Fasting—the ultimate diet? Obes Rev 2007; 8: 211–22 CrossRef MEDLINE
e33.
WMA: Declaration of Malta on hunger strikers 1991/2017. www.wma.net/policies-post/wma-declaration-of-malta-on-hunger-strikers/ (last accessed on 6 August 2018).
e34.
Pfeiffer-Gerschel T, Dammer EPD: Kurzbericht Situation illegaler Drogen in Deutschland (Datenjahr 2016/1017). IFT 2018.
e35.
Freissmuth M, Offermanns S, Böhm S: Pharmakologie und Toxikologie: Berlin, Heidelberg: Springer 2016.
e36.
Schulte L, Dammer E, Pfeiffer, T, Bartsch G, Friedrich M: Bericht des nationalen REITOX-Knotenpunkts an die EBDD. Datenjahr 2011.
e37.
Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N: Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev 2016: CD011117 MEDLINE
Prison Hospital Berlin, JVA Plötzensee, Berlin: Dr. med. Annette Opitz-Welke,
Dr. med. Marc Lehmann, Peter Seidel
Institute of Forensic Psychiatry, Charité-Universitätsmedizin Berlin:
Prof. Dr. med. Norbert Konrad
Key messages
Comparison of medical care for the resident population and prisoners
Comparison of medical care for the resident population and prisoners
Table 1
Comparison of medical care for the resident population and prisoners
Rates of health impairments and causes of death in prison inmates
Rates of health impairments and causes of death in prison inmates
Table 2
Rates of health impairments and causes of death in prison inmates
Communicable diseases in the general population versus prison population in Germany
Communicable diseases in the general population versus prison population in Germany
Table 3
Communicable diseases in the general population versus prison population in Germany
Psychiatric disorders in prisoners
Psychiatric disorders in prisoners
Table 4
Psychiatric disorders in prisoners
Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)
Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)
Table 5
Suicide rates in prisons in Germany in 2000–2011 compared to residential population (18)
1.Meier BD: Ärztliche Versorgung im Strafvollzug: Äquivalenzprinzip und Ressourcenknappheit. In: Hillenkamp T, Tag B (eds.): Intramurale Medizin – Gesundheitsfürsorge zwischen Heilauftrag und Strafvollzug. Berlin, Heidelberg: Springer 2005: 35–55 CrossRef
2.Keppler K, Stover H, Schulte B, Reimer J: [Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany. A review]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53: 233–44 CrossRef MEDLINE
3.Feron JM, Paulus D, Tonglet R, Lorant V, Pestiaux D: Substantial use of primary health care by prisoners: epidemiological description and possible explanations. J Epidemiol Community Health 2005; 59: 651–5 CrossRef MEDLINE PubMed Central
4.Parker DR, Fallone D, Martin RA, et al.: The relation between smoking status and medical conditions among incarcerated adults. J Addict Med 2014; 8: 90–5 CrossRef MEDLINE PubMed Central
5.Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP: Dynamic models of infectious disease transmission in prisons and the general population. Epidemiol Rev 2018; 40: 40–57 CrossRef MEDLINE
6.Dolan K, Wirtz AL, Moazen B, et al.: Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 2016; 388: 1089–102 CrossRef
7.Zimmermann R, Radun D: DrogengebraucherInnen, Infektionen und Haft. Schriftenreihe Gesund­heits­förder­ung im Justizvollzug 2014; Band 28: 13–31.
8.Ziegler R, Just HM, Castell S, et al.: [Tuberculosis infection control—recommendations of the DZK]. Gesundheitswesen 2012; 74: 337–50 CrossRef MEDLINE
9.Aerts A, Hauer B, Wanlin M, Veen J: Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 2006; 10: 1215–23 MEDLINE
10.Edge CL, King EJ, Dolan K, McKee M: Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc 2016; 19: 20960 CrossRef MEDLINE PubMed Central
11.Fazel S, Seewald K: Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry 2012; 200: 364–73 CrossRef MEDLINE
12.Gößling J, Konrad N: Zur Entität der sogenannten Haftpsychose. Recht und Psychiatrie 2004; 22: 123–9.
13.Young SJ, Adamou M, Bolea B, et al.: The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK adult ADHD network and criminal justice agencies. BMC Psychiatry 2011; 11: 32 CrossRef MEDLINE PubMed Central
14.Ginsberg Y, Lindefors N: Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. Br J Psychiatry 2012; 200: 68–73 CrossRef MEDLINE
15.Fazel S, Cartwright J, Norman-Nott A, Hawton K: Suicide in prisoners: a systematic review of risk factors. J Clin Psychiatry 2008; 69: 1721–31 CrossRef MEDLINE
16.Felthous AR: Suicide behind bars: trends, inconsistencies, and practical implications. J Forensic Sci 2011; 56: 1541–55 CrossRef MEDLINE
17.Konrad N, Welke J, Opitz-Welke A: Prison psychiatry. Curr Opin Psychiatry 2012; 25: 375–80 CrossRef
18.Opitz-Welke A, Bennefeld-Kersten K, Konrad N, Welke J: Prison suicides in Germany from 2000 to 2011. Int J Law Psychiatry 2013; 36: 386–9 CrossRef MEDLINE
19.Gould C, McGeorge T, Slade K: Suicide screening tools for use in incarcerated offenders: a systematic review. Arch Suicide Res 2018; 22: 345–64 CrossRef MEDLINE
20.Bielen R, Stumo SR, Halford R, et al.: Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J 2018; 15: 25 CrossRef MEDLINE PubMed Central
21. Wirtz AL, Yeh PT, Flath NL, Beyrer C, Dolan K: HIV and viral hepatitis among imprisoned key populations. Epidemiol Rev 2018; 40: 12–26 CrossRef MEDLINE
22.Michel L, Lions C, van Malderen S, et al.: Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern. BMC Public Health 2015; 15: 1093 CrossRef MEDLINE PubMed Central
23.Stark K, Herrmann U, Ehrhardt S, Bienzle U: A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect 2006; 134: 814–9 CrossRef MEDLINE PubMed Central
24.Karakaya S: Auswirkungen der Spritzenvergabe im Justizvollzug auf Drogenkonsumverhalten mit Hepatitis B, C und HIV. Universitätsmedizin Berlin. Berlin: Charite 2009: 106.
25.Muller J, Schmidt D, Kollan C, Lehmann M, Bremer V, Zimmermann R: High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany. BMC Public Health 2017; 17: 843 CrossRef MEDLINE PubMed Central
26.Hawton K, Linsell L, Adeniji T, Sariaslan A, Fazel S: Self-harm in prisons in England and Wales: an epidemiological study of prevalence, risk factors, clustering, and subsequent suicide. Lancet 2014; 383: 1147–54 CrossRef
27.Marzano L, Hawton K, Rivlin A, Smith EN, Piper M, Fazel S: Prevention of suicidal behavior in prisons. Crisis 2016; 37: 323–34 CrossRef MEDLINE PubMed Central
28.Gardner KJ, Dodsworth J, Klonsky ED: Reasons for non-suicidal self-harm in adult male offenders with and without borderline personality traits. Arch Suicide Res 2016; 20: 614–34 CrossRef MEDLINE
29.Evans DC, Wojda TR, Jones CD, Otey AJ, Stawicki SP: Intentional ingestions of foreign objects among prisoners: a review. World J Gastrointest Endosc 2015; 7: 162–8 CrossRef MEDLINE PubMed Central
30.Blaho KE, Merigian KS, Winbery SL, Park LJ, Cockrell M: Foreign body ingestions in the emergency department: case reports and review of treatment. J Emerg Med 1998; 16: 21–6 CrossRef
31.Mir J, Kastner S, Priebe S, Konrad N, Strohle A, Mundt AP: Treating substance abuse is not enough: comorbidities in consecutively admitted female prisoners. Addict Behav 2015; 46: 25–30 CrossRef MEDLINE
32.Fazel S, Hayes AJ, Bartellas K, Clerici M, Trestman R: Mental health of prisoners: prevalence, adverse outcomes, and interventions. Lancet Psychiatry 2016; 3: 871–81 CrossRef
33.Kouyoumdjian FG, Andreev EM, Borschmann R, Kinner SA, McConnon A: Do people who experience incarceration age more quickly? Exploratory analyses using retrospective cohort data on mortality from Ontario, Canada. PLoS One 2017; 12: e0175837 CrossRef CrossRef MEDLINE PubMed Central
34.Binswanger IA, Blatchford PJ, Mueller SR, Stern MF: Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 2013; 159: 592–600 CrossRef MEDLINE PubMed Central
35.Groot E, Kouyoumdjian FG, Kiefer L, et al.: Drug toxicity deaths after release from incarceration in Ontario, 2006–2013: review of coroner‘s cases. PLoS One 2016; 11: e0157512 CrossRef MEDLINE PubMed Central
36.Merrall EL, Kariminia A, Binswanger IA, et al.: Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105: 1545–54 CrossRef MEDLINE PubMed Central
37.Degenhardt L, Larney S, Kimber J, et al.: The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction 2014; 109: 1306–17 CrossRef MEDLINE
38.Mundt AP, Kastner S, Mir J, Priebe S: Did female prisoners with mental disorders receive psychiatric treatment before imprisonment? BMC Psychiatry 2015; 15: 5 CrossRef MEDLINE PubMed Central
39.Larney S, Kopinski H, Beckwith CG, et al.: Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 2013; 58: 1215–24 CrossRef MEDLINE PubMed Central
40.Fazel S, Fiminska S, Cocks C, Coid J: Patient outcomes following discharge from secure psychiatric hospitals: systematic review and meta-analysis. Br J Psychiatry 2016; 208: 17–25 CrossRef MEDLINE PubMed Central
e1.Wamsly R: World prison population list. London: International Center for Prison Studies. 2016; 11.
e2. Statistisches Bundesamt: Bestand der Gefangenen und Verwahrten in den deutschen Justizvollzugsanstalten. Rechtspflege 2017: 1–55.
e3.DKG: Eckdaten Krankenhausstatistik. www.dkgev.de/media/file/64821.Eckdaten_Krankenhausstatistik_Stand_2017–10–05.pdf (last accessed on 29 July 2018).
e4.Keppler K: Versorgung in Krankenhäusern des Justizvollzugs. In: Keppler K, Stöver H (eds): Gefängnismedizin Stuttgart, Thieme 2009.
e5.KBV: Gesundheitsdaten. http://gesundheitsdaten.kbv.de/cms/html/16393.php (last accessed on 29 July 2018)
e6.Møller L, Stöver H, Jürgens R, Gatherer A, Nikogosian H: Health in prisons. WHO 2007. http://www.euro.who.int/__data/assets/pdf_file/0009/99018/E90174.pdf (last accessed on 29 July 2018).
e7.Baillargeon J, Black SA, Pulvino J, Dunn K: The disease profile of Texas prison inmates. Ann Epidemiol 2000; 10: 74–80 CrossRef
e8.Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J: Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Int J Prison Health 2009; 5: 33–44.
e9.Maruschak LB, Berzofsky M, Unangst J: Medical problems of state and federal prisons and jail inmates. U.S. Department of Justice 2015. www.bjs.gov/content/pub/pdf/mpsfpji1112.pdf (last accessed 29 July 2018).
e10.Moschetti K, Stadelmann P, Wangmo T, et al.: Disease profiles of detainees in the Canton of Vaud in Switzerland: gender and age differences in substance abuse, mental health and chronic health conditions. BMC Public Health 2015; 15: 872 CrossRef MEDLINE PubMed Central
e11. Binswanger IA, Krueger PM, Steiner JF: Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health 2009; 63: 912–9 CrossRef MEDLINE
e12.Kouyoumdjian FG, Kiefer L, Wobeser W, Gonzalez A, Hwang S: Mortality over 12 years of follow up in people admitted to provincial custody in Ontarion: a retrospective cohort study. CAMJ Open 2016; 4: E153–61 CrossRef MEDLINE PubMed Central
e13.RKI: Epidemiologisches Bulletin 2018; 11/12. Tuberkulose bleibt eine Herausforderung – auch für Deutschland. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben 11–12_18.pdf?__ blob=publicationFile (last accessed on 29 July 2018).
e14.Kamarulzaman A, Reid SE, Schwitters A, et al.: Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet 2016; 388: 1115–26 CrossRef
e15.RKI: Schätzung der Zahl der HIV-Neuinfektionen und der Gesamt-zahl von Menschen mit HIV in DeutschlandEpidemiologisches Bulletin 2017; 47. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/47_17.pdf?__blob=publicationFile (last accessed on 28. August 2018).
e16.RKI: Hepatitis C im Jahr 2016. Epidemiologisches Bulletin 2017; 30. www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/30_17.pdf?__blob=publicationFile (last accessed on 29 July 2018).
e17.Paquette K, Cheng MP, Kadatz MJ, Cook VJ, Chen W, Johnston CJ: Chest radiography or active tuberculosis finding in the homeless: a systematic review and meta-analysis. Inter J Tuberc Lung Dis 2014; 18: 1231–6 CrossRef MEDLINE
e18.Farhoudi B, Seyed Alinaghi S, Hosseini M, et al.: Prevalence of tuberculosis in a prison in Tehran by active case finding. Infect disord drug targets 2018. [Epub ahead of print]
e19. Bundesministeriums der Justiz und für Verbraucherschutz in Zusammenarbeit mit der juris GmbH: Justiz Bd: IfSG 2001. www.gesetze-im-internet.de/ifsg/IfSG.pdf (last accessed on 29 July .2018).
e20.Bös L: Tuberkulose im Justizvollzug. Ergebnisse einer Arbeitstagung. DZK 2013. www.rki.de/DE/Content/InfAZ/T/Tuberkulose/WTBTag2014/Vortrag_06.pdf?__blob=publicationFile (last accessed on 29 July 2018).
e21. Konrad N: Ersatzfreiheitsstrafe Psychische Störungen, forensische und soziodemographische Aspekte. ZfstrVo 2003: 216–23.
e22.Missoni L, Utting FM, Konrad N: Psychi(atri)sche Störungen bei Untersuchungsgefangenen. Ergebnisse und Probleme einer epidemiologischen Studie. ZfStrVo 2003: 323–32.
e23.von Schonfeld CE, Schneider F, Schroder T, Widmann B, Botthof U, Driessen M: [Prevalence of psychiatric disorders, psychopathology, and the need for treatment in female and male prisoners]. Nervenarzt 2006; 77: 830–41 MEDLINE
e24.Müller-Foti G, Roberts FJ, Schildbach S, Wickenhäuser R: Punishing the disorientaded. Int J Prisoner Health 2007: 115–23.
e25.Dudeck M, Kopp D, Kuwert P, et al.: [Prevalence of psychiatric disorders in prisoners with a short imprisonment: results from a prison in north Germany]. Psychiatr Prax 2009; 36: 219–24 CrossRef MEDLINE
e26.Schildbach S: Ersatzfreiheitsstrafe. Unterensingen: Saturia 2015; 245–86.
e27.Young S, Moss D, Sedgwick O, Fridman M, Hodgkins P: A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psycholg Med.2015 Jan; 45 (2): 247–78 CrossRef MEDLINE PubMed Central
e28.Rosler M, Retz W, Yaqoobi K, Burg E, Retz-Junginger P: Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 2009; 259: 98–105 CrossRef MEDLINE
e29.Frottier P, Koenig F, Seyringer M, Matschnig T, Fruehwald S: The distillation of „VISCI“: towards a better identification of suicidal inmates. Suicide Life Threat Behav 2009; 39: 376–85 CrossRef MEDLINE
e30.Lohner J, Konrad N: Deliberate self harm and suicide attempt in custody: distinguishing featurs in male inmates‘ self injourious behaviour. Int J Law Psychiatry 2006; 29: 370–85 CrossRef MEDLINE
e31. Reeves R, Tamburello AC, Platt J, Tepper D, Edelman K: Characteristics of inmates who initiate hunger strikes. J Am Acad Psychiatry Law 2017; 45: 302–10 MEDLINE
e32.Johnstone AM: Fasting—the ultimate diet? Obes Rev 2007; 8: 211–22 CrossRef MEDLINE
e33. WMA: Declaration of Malta on hunger strikers 1991/2017. www.wma.net/policies-post/wma-declaration-of-malta-on-hunger-strikers/ (last accessed on 6 August 2018).
e34. Pfeiffer-Gerschel T, Dammer EPD: Kurzbericht Situation illegaler Drogen in Deutschland (Datenjahr 2016/1017). IFT 2018.
e35.Freissmuth M, Offermanns S, Böhm S: Pharmakologie und Toxikologie: Berlin, Heidelberg: Springer 2016.
e36.Schulte L, Dammer E, Pfeiffer, T, Bartsch G, Friedrich M: Bericht des nationalen REITOX-Knotenpunkts an die EBDD. Datenjahr 2011.
e37.Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N: Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev 2016: CD011117 MEDLINE